Cancer registry

AION Labs Launches CombinAble.AI to Reduce Time and Cost of Targeted Antibody Design, Advancing Optimization of Drug Development

Retrieved on: 
Tuesday, March 12, 2024
Knowledge, Cancer registry, AI, Doctor of Philosophy, AION, Safety, Therapy, Lead, Medical device

REHOVOT, Israel, March 12, 2024 /PRNewswire/ -- AION Labs, the first-of-its-kind venture studio spearheading the adoption of AI technologies and computational science to solve therapeutic challenges, announced today the launch of CombinAble.AI. The new startup has been created to address the challenges associated with antibody design in order to enhance and accelerate the development of more effective therapeutics.

Key Points: 
  • CombinAble was formed following an AION Labs' startup challenge aimed at developing an AI solution for the optimization of therapeutic antibodies.
  • Antibody optimization is a critical step in the drug development pipeline, transforming a preliminary functional antibody hit into a clinical drug candidate by enhancing multiple characteristics related to its safety, efficacy, and manufacturability.
  • CombinAble is the latest startup launched by AION Labs, through the investment and support of global pharmaceutical and technology leaders.
  • "The launch of CombinAble heralds a shift in the approach to targeted antibody design by leveraging AI to optimize and expedite the discovery process," said Mati Gill, CEO of AION Labs.

GeBBS Healthcare Solutions Acquires MRA (Medical Record Associates, LLC)

Retrieved on: 
Thursday, October 5, 2023
MRA, Health care, Acquisition, Family, Cancer registry, Clinical coder, LOS, Revenue cycle management, HIM, Katrin Gebbe, RCM, Pharmaceutical industry, Consultant

LOS ANGELES, Oct. 5, 2023 /PRNewswire-PRWeb/ -- GeBBS Healthcare Solutions, Inc.(ChrysCapital portfolio company) a leading provider of technology enabled Revenue Cycle Management (RCM) HIM & Risk Adjustment Solutions for Healthcare Providers and Payers, announced today the acquisition of MRA, a Boston, MA based provider of HIM, Auditing and cancer registry services.

Key Points: 
  • GeBBS Healthcare Solutions, Inc.(ChrysCapital portfolio company) a leading provider of technology enabled Revenue Cycle Management (RCM) HIM & Risk Adjustment Solutions for Healthcare Providers and Payers, announced today the acquisition of MRA, a Boston, MA based provider of HIM, Auditing and cancer registry services.
  • LOS ANGELES, Oct. 5, 2023 /PRNewswire-PRWeb/ -- GeBBS Healthcare Solutions, Inc.(ChrysCapital portfolio company) a leading provider of technology enabled Revenue Cycle Management (RCM) HIM & Risk Adjustment Solutions for Healthcare Providers and Payers, announced today the acquisition of MRA, a Boston, MA based provider of HIM, Auditing and cancer registry services.
  • "We are excited to partner with MRA to expand GeBBS' services and expertise in the middle revenue cycle, in particular in Medical Coding, Auditing, and Cancer Registry," said Milind Godbole, CEO and Managing Director, GeBBS Healthcare Solutions.
  • "GeBBS acquisition of MRA creates a national leader in the outsourced, end-to-end Revenue Cycle Services and Technology market," said Charlie Saponaro, CEO, MRA.

OncoHealth Named One of the Top Workplaces for 2022 by The Atlanta Journal-Constitution

Retrieved on: 
Monday, March 14, 2022
People, Empathy, Cancer, Cancer registry, Patient, The Atlanta Journal-Constitution, Culture, CEO, Workforce, Multimedia, Management, Medicine, Atlanta

ATLANTA, March 14, 2022 /PRNewswire/ -- OncoHealth , aleading digital health company dedicated to oncology, has been awarded a Top Workplaces 2022 honor by The Atlanta Journal-Constitution, the company announced today.

Key Points: 
  • ATLANTA, March 14, 2022 /PRNewswire/ -- OncoHealth , aleading digital health company dedicated to oncology, has been awarded a Top Workplaces 2022 honor by The Atlanta Journal-Constitution, the company announced today.
  • The company's commitment to building a collaborative and inclusive work culture has been a priority since its inception over 10 years ago.
  • The employee feedback that led to this award shows these attributes are embraced as our company's strengths."
  • Most of our team has a story and a reason why they work here," said Rick Dean, OncoHealth's CEO.

New peer-reviewed study confirms Transpara® AI by ScreenPoint Medical improves accuracy when reading 3D mammograms, with no increase in reading time

Retrieved on: 
Friday, October 1, 2021
Cancer, Artificial intelligence, Efficiency, Breast cancer, Workflow, FDA, Mammography, AI, 3D, CE, 2D, Deep learning, Cancer registry, DBT, Tomosynthesis, Medical imaging

And now, Radiology, an important publication, reveals details of more benefits of using Transpara breast AI with 3D mammography.

Key Points: 
  • And now, Radiology, an important publication, reveals details of more benefits of using Transpara breast AI with 3D mammography.
  • Transpara, which is based on deep learning technology, is FDA cleared and CE marked for both 2D and 3D mammography.
  • In addition, this study highlights the improvements in accuracy that can be realised using AI as decision support.
  • Transpara has been used in more than 1.6 million mammograms - proof that ScreenPoint Medical is delivering on its mission to bring effective AI to the fight against breast cancer."

OSF HealthCare Selects Inspirata as Its Cancer Informatics Solution Provider

Retrieved on: 
Tuesday, July 20, 2021
Health, OSF Healthcare, Health informatics, Cancer registry, OSF

Tampa, Florida, July 20, 2021 (GLOBE NEWSWIRE) -- Cancer informatics and digital pathology provider Inspirata announced today a new partnership with the integrated health system OSF HealthCare.

Key Points: 
  • Tampa, Florida, July 20, 2021 (GLOBE NEWSWIRE) -- Cancer informatics and digital pathology provider Inspirata announced today a new partnership with the integrated health system OSF HealthCare.
  • Under this partnership, OSF HealthCare will leverage Inspiratas data abstraction solution, E-Path Plus, to instantly interpret the text of diagnostic reports, identify reportable cases, and route them directly to the relevant cancer registry.
  • OSF HealthCare, through OSF Home Care Services, operates an extensive network of home health and hospice services.
  • Our comprehensive cancer informatics solutions bring disparate data together throughout the entire cancer care journey to drive informed decisions that improve survivorship.

Inspirata Extends Multi-Year Partnership with the Victorian Cancer Registry

Retrieved on: 
Wednesday, June 30, 2021
Oncology, Health, Cancer registry, Epidemiology of cancer, Medicine, Cancer Council Victoria, Cancer

Tampa, Florida, June 30, 2021 (GLOBE NEWSWIRE) -- Cancer informatics and digital pathology provider Inspirata announced today a multi-year extension of its close partnership with one of the worlds leading cancer registries, the Victorian Cancer Registry (VCR) in Australia.

Key Points: 
  • Tampa, Florida, June 30, 2021 (GLOBE NEWSWIRE) -- Cancer informatics and digital pathology provider Inspirata announced today a multi-year extension of its close partnership with one of the worlds leading cancer registries, the Victorian Cancer Registry (VCR) in Australia.
  • An important part of the Cancer Council Victoria, the Victorian Cancer Registry documents all instances of reportable cancer originating within the Australian state of Victoria, using this data to inform cancer policy development and monitor policy impact on cancer incidence, survival and mortality, and to release data for research purposes.
  • Inspirata previously ran a pilot for its cancer reporting automation solution, E-Path, in two Victorian laboratories with the intention of improving the cancer reporting process.
  • The Victorian Cancer Registry, funded by the Victorian Department of Health keeps a record of people with cancer in Victoria.

Inspirata Announces Platinum Sponsorship of NCRA 2021

Retrieved on: 
Thursday, June 3, 2021
National Cancer Registrars Association, Cancer registry, Oncology, Cancer, Health, Medicine

Tampa, Florida, June 03, 2021 (GLOBE NEWSWIRE) -- Cancer informatics and digital pathology provider Inspirata announced today that it is a Platinum Sponsor of the 47th Annual National Cancer Registrars Association (NCRA) Educational Conference, taking place virtually from June 3rd to June 5th.

Key Points: 
  • Tampa, Florida, June 03, 2021 (GLOBE NEWSWIRE) -- Cancer informatics and digital pathology provider Inspirata announced today that it is a Platinum Sponsor of the 47th Annual National Cancer Registrars Association (NCRA) Educational Conference, taking place virtually from June 3rd to June 5th.
  • As part of its partnership with NCRA, Inspirata will be hosting a virtual booth where conference attendees can speak to an Inspirata representative and learn more about the E-Path suite of cancer reporting and data abstraction solutions.
  • Inspirata, Inc. helps patients fighting cancerand the clinicians they trustto make every moment matter.
  • Inspirata has assembled the most advanced and proven technologies to address the complex challenges of delivering cancer care and conducting ground-breaking research.

Inspirata Celebrates the Vital Work of Cancer Registrars for National Cancer Registrars Week

Retrieved on: 
Monday, April 5, 2021
Cancer registry, Oncology, Health, Cancer, Medicine

Tampa, Florida, April 05, 2021 (GLOBE NEWSWIRE) -- Cancer informatics and digital pathology provider Inspirata looks forward to celebrating the 25th annual National Cancer Registrars Week (NCRW) during the week of April 5th, 2021.

Key Points: 
  • Tampa, Florida, April 05, 2021 (GLOBE NEWSWIRE) -- Cancer informatics and digital pathology provider Inspirata looks forward to celebrating the 25th annual National Cancer Registrars Week (NCRW) during the week of April 5th, 2021.
  • This years theme, Cancer Registrars: The Driving Force of Cancer Data, reflects the critical role cancer registrars play in capturing the data that informs cancer prevention and screening programs, treatment, and research.
  • Quality cancer data is central to the nations fight against cancer, and cancer registrars are the first link in capturing that data.
  • National Cancer Registrars Week provides an opportunity to acknowledge the central role registrars play.

Theresa Vallerand of Ciox Awarded NCRA's 2020 Distinguished Member Award

Retrieved on: 
Tuesday, February 2, 2021
National Cancer Registrars Association, NCRA, Cancer registry

ALPHARETTA, Ga., Feb. 2, 2021 /PRNewswire/ -- Ciox , a leading health technology company, today announces that Theresa "Terry" Vallerand, BGS, CTR, has won the Distinguished Member Award from The National Cancer Registrars Association (NCRA).

Key Points: 
  • ALPHARETTA, Ga., Feb. 2, 2021 /PRNewswire/ -- Ciox , a leading health technology company, today announces that Theresa "Terry" Vallerand, BGS, CTR, has won the Distinguished Member Award from The National Cancer Registrars Association (NCRA).
  • Terry is the Senior Manager and Education Coordinator of Oncology Data Services within the Real World Data (RWD) Division of Ciox.
  • The Distinguished Member Award honors an NCRA member for outstanding contributions to the profession, encouraging in members the desire to contribute to the profession's development and growth and furthering public awareness of the scope and importance of the profession.
  • In 2019, Terry was presented with the Volunteer Excellence Award, which acknowledged her proven commitment to the cancer registry profession through her NCRA volunteer work.

National Cancer Institute (NCI) Extends Long-Standing Partnership with Inspirata

Retrieved on: 
Tuesday, September 29, 2020
Oncology, Health, Cancer, Medical specialties, Cancer registry, National Cancer Institute, Cancer research, Surveillance, Epidemiology, and End Results

Tampa, Florida, Sept. 29, 2020 (GLOBE NEWSWIRE) -- Inspirata announced today the renewal of its long-standing partnership with the National Cancer Institute (NCI).

Key Points: 
  • Tampa, Florida, Sept. 29, 2020 (GLOBE NEWSWIRE) -- Inspirata announced today the renewal of its long-standing partnership with the National Cancer Institute (NCI).
  • SEER has regulatory authority through the NCI to collect and publish data on every cancer case reported from 19 U.S. geographic areas.
  • The NCI requires participating cancer registries to collect data on cancer patient demographics, primary tumor site, tumor morphology and disease stage at diagnosis.
  • Our comprehensive cancer informatics solutions bring disparate data together throughout the entire cancer care journey to drive informed decisions that improve survivorship.